Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Biotricity Inc. (BTCY : OTC)

• Company Description    Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada. Number of Employees: 46

• Price / Volume Information    Yesterday's Closing Price: $0.73 Daily Weekly Monthly 20 Day Moving Average: 30,345 shares Shares Outstanding: 24.91 (millions) Market Capitalization: $18.18 (millions) Beta: 1.19 52 Week High: $0.83 52 Week Low: $0.19 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 35.13% 32.69% 12 Week 58.63% 44.02% Year To Date 151.71% 124.74%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 203 Redwood Shores Parkway Suite 600 - REDWOOD CITY,CA 94065 USA ph: 800-590-4155 fax: - investors@biotricity.com http://www.biotricity.com

• General Corporate Information    Officers Waqaas Al-Siddiq - Chairman; President and Chief Executive Officer John Ayanoglou - Chief Financial Officer David A. Rosa - Director Jainal Bhuiyan - Director Ronald McClurg - Director Peer Information Biotricity Inc. (HLIS) Biotricity Inc. (AZTA) Biotricity Inc. (APYI) Biotricity Inc. (RNVA) Biotricity Inc. (HMSY) Biotricity Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 09074H203 SIC: 3841 Fiscal Year Fiscal Year End: March Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/13/25 Share - Related Items Shares Outstanding: 24.91 Most Recent Split Date: 7.00 (0.17:1) Beta: 1.19 Market Capitalization: $18.18 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.08 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.32 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 1.26 EPS Growth vs. Year Ago Period: 93.88% vs. Previous Quarter: 50.00% Sales Growth vs. Year Ago Period: 20.99% vs. Previous Quarter: 4.62% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - -94.07 03/31/25 - -150.79 12/31/24 - -188.47 Current Ratio 06/30/25 - 0.24 03/31/25 - 0.22 12/31/24 - 0.23 Quick Ratio 06/30/25 - 0.15 03/31/25 - 0.15 12/31/24 - 0.16 Operating Margin 06/30/25 - -37.33 03/31/25 - -61.07 12/31/24 - -80.42 Net Margin 06/30/25 - -37.33 03/31/25 - -61.07 12/31/24 - -80.42 Pre-Tax Margin 06/30/25 - -37.32 03/31/25 - -61.07 12/31/24 - -80.42 Book Value 06/30/25 - -1.32 03/31/25 - -1.29 12/31/24 - -1.30 Inventory Turnover 06/30/25 - 1.87 03/31/25 - 1.88 12/31/24 - 1.90 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©